Alfacalcidol 0.25mg/0.5mcg capsules,
List of Related Indications:
List Of Drugs:
Indication Type Description:
Dosages/ Overdosage Etc
Interaction with Food
Concurrent digitalis preparation may precipitate cardiacarrhythmias.
Thiazide diuretics cause hypercalcaemia by increasing renal tubular reabsorption of calcium and thus increase the hypercalcaemic response to alfacalcidol.
Phenobarbitone and other enzymes-inducers may reduce activation of alfacalcidol into calcitriol.
Prolonged use of mineral oil may reduce absorption.
Cholestyramine, cholestipol, sucralfate or large amounts of aluminium based antacids may also reduce absorption.
Hypermagnesiumia may occur with concomittant use of magnesium based antacids or laxatives in those on chronic renal dialysis.
Hypercalcaemia.In case of renal impairment,hyperphosphataemia.
In hypercalcaemic patients possibility of calcium influx from the dialysate should be considered.
Increased risks of renal stones.
Hypercalcemia,hyperphosphataemia(except when occuring with hypothyroidism), hypermagnesiumia,
Vit D toxicity or known hypersens effects of Vit D.
Pregnancy and lactation,
renal impairment, elderly.
Monitor serum levels in patients with renal failure.
Caution in hypercalcuria esp in those with history of renal calculli.
Dosages/ Overdosage Etc:
Initially 0.5mg daily adjusted according to response
Children- 0.04mg/kg daily
Take with food
Interaction with Food:
Take with food